Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPanthera Res. Regulatory News (PAT)

Share Price Information for Panthera Res. (PAT)

Share Price is delayed by 15 minutes
Get Live Data
18.20    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.00 (5.556%)
Market Cap: £47.12m
PAT Live PriceLast checked at - London Stock Exchange

Intraday Panthera Res. Share Chart

SECOND TRANCHE EQUITY SUBSCRIPTION

8 Jan 2018 07:42

RNS Number : 2003B
Panthera Resources PLC
08 January 2018
 

 

 

 

 

8 January 2018

 

 

 

8 January 2018

 

Panthera Resources PLC

("Panthera" or "the Company")

 

SECOND TRANCHE EQUITY SUBSCRIPTION

 

Panthera Resources PLC (AIM: PAT), the gold exploration and development company with key assets in India and West Africa, announces that it has received the second tranche equity subscription of A$2m at A$0.35 (approximately 20 pence) per share, from Republic Investment Management Pte Ltd ("Republic") in accordance with the Investment Agreement dated 14 June 2017. The Company has issued 5,714,286 New Ordinary Shares to Republic and its co-investors.

 

Timothy Hargreaves, a director at the Company has subscribed for 214,285 New Ordinary Shares as part of the second tranche equity subscription. Following the issue of these New Ordinary Shares, Timothy Hargreaves has an interest in 514,285 Ordinary Shares representing 0.76 per cent. of the issued share capital of the Company.

 

The final third tranche of A$2.7m which will be issued at a price of A$0.65 per share will be due upon the prospecting licence being granted for the Bhukia Project and the necessary environmental and forestry permits for drilling being obtained.

 

The 5,714,286 New Ordinary Shares are expected to be admitted to trading on AIM on or around 11 January 2018. Following the issue of the New Ordinary Shares, the number of Ordinary Shares in issue in the Company will increase to 67,605,556.

 

For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules ("DTRs"), the issued Ordinary Share capital of Panthera following this allotment consists of 67,605,556 Ordinary Shares with voting rights attached (one vote per share). There are no shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, Panthera under the DTRs.

 

Enquiries:

 

Panthera Resources PLC

Geoff Stanley (CEO) +1 (917) 941 7704

 

Nominated Advisor and Broker

RFC Ambrian +44 (0) 20 3440 6800

Nominated Adviser

Rob Adamson

Bhavesh Patel

Broker

Charlie Cryer

Jonathan Williams

 

Financial Public Relations

Blytheweigh +44 (0) 20 138 3204

Camilla Horsfall

Nick Elwes

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEFKFDNOBKKNDK
Date   Source Headline
3rd Jun 20267:00 amRNS-ROnline Investor Webinar
29th May 20265:15 pmRNSTotal Voting Rights
21st May 20267:00 amRNSConversion of Options
6th May 20267:00 amRNSConversion of Options
30th Apr 20265:00 pmRNSTotal Voting Rights
14th Apr 20267:09 amRNSConversion of Options
9th Apr 20262:31 pmRNSIssue of Equity – In Lieu of Director Fees
2nd Mar 20267:00 amRNSArbitration Update
19th Jan 20267:00 amRNSBido Drilling Results
31st Dec 202512:45 pmRNSTotal Voting Rights
31st Dec 202512:45 pmRNSTotal Voting Rights
29th Dec 20257:00 amRNSHalf-year Financial Report
29th Dec 20257:00 amRNSHalf-year Financial Report
11th Dec 20257:00 amRNSWarrant Conversion
3rd Dec 20257:00 amRNSWarrant Conversion
1st Dec 20257:00 amRNSTotal Voting Rights
25th Nov 20258:59 amRNSWarrant Conversion
21st Nov 20257:00 amRNSKalaka Metallurgical Study Results
20th Nov 20252:00 pmRNSWarrant Conversion
17th Nov 20257:00 amRNSOTCQB Approval
12th Nov 20257:00 amRNSOTC Application
3rd Nov 202511:02 amRNSIssue of Equity - Warrant Conversion and Fees
31st Oct 20255:05 pmRNSTotal Voting Rights
29th Oct 20257:00 amRNSArbitration Update
16th Oct 20255:05 pmRNSWarrant Conversion
9th Oct 202510:31 amRNSWarrant Conversion
8th Oct 20257:00 amRNSArbitration Financing Facility Update
3rd Oct 202511:30 amRNSResult of AGM
29th Sep 20257:00 amRNSChange of Registered Office
18th Sep 20257:00 amRNSArbitration Update
29th Aug 20255:00 pmRNSTotal Voting Rights
27th Aug 20257:58 amRNS2025 Annual Financial Report
8th Aug 20257:00 amRNSOption Conversion
4th Aug 20257:00 amRNSCommencement of Cascades Feasibility Study
25th Jul 20257:32 amRNSWarrant Conversion
18th Jul 20257:00 amRNSBido Drilling
19th May 20257:00 amRNSUS$1.58 billion Claim for Damages
30th Apr 20255:00 pmRNSTotal Voting Rights
16th Apr 20253:54 pmRNSIssue of Equity - Warrant Conversion and Fees
31st Mar 20255:00 pmRNSTotal Voting Rights
27th Mar 20257:00 amRNSIssue of Equity - Conversion of Options
20th Mar 202510:37 amRNSWarrant Exercise
7th Mar 20255:35 pmRNSNotification of Major Holding
6th Mar 20254:45 pmRNSUpdate on Issue of Equity Fundraising
28th Feb 20255:32 pmRNSNotification of Major Holding
25th Feb 20257:47 amRNSResult of Placing and Subscription
24th Feb 20255:04 pmRNSIssue of Equity
21st Feb 20255:00 pmRNSWarrant Exercise
20th Feb 20256:11 pmRNSNotifications of Major Holdings
4th Feb 20257:00 amRNSMaiden JORC Resource Estimate for Kalaka Project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.